PharmaShots

MAY 5, 2023

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive EC’s Marketing Authorization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease Date: May 05, 2023 | Tags: Chiesi Global Rare Diseases, Protalix BioTherapeutics, PRX-102, pegunigalsidase alfa, Fabry Disease, Regulatory, EC, Marketing Authorization Kinoxis Therapeutics (..)

Biosimilars 40

Biosimilars 40

PharmaState Academy

JUNE 24, 2023

The Power of Sound in a Tagline Neuroscience has proved that sound has a profound impact on human emotions and memory. That’s the power of sound in a tag line. A strong ‘Voice of Your Brand’ evokes emotions, builds trust, and creates a lasting impression in the minds of doctors and may be even the patients.

Communication 52

Communication 52

PharmaShots

MARCH 9, 2023

in Neuroscience from the University of Cambridge. She developed various mobile technologies and pioneered early electronic labels including NFC tags, which helped Thin Film Electronics win the Wall Street Innovation Award and the Global Technology Award. Education: She gained her Ph.D. LinkedIn Total experience: 16 yrs.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40